The introduction of a 750mcg teriparatide solution in Australia has sparked considerable discussion within the healthcare community. Currently, its availability is carefully managed, primarily via specialist doctors and registered centers. Revenue figures for this specific dosage remain somewhat difficult to ascertain, but indications suggest a slo